FDA halts use of Regeneron, other monoclonal antibody COVID treatment, DeSantis says move ‘reckless’
The Food and Drug Administration has removed two monoclonal antibody therapies from its list of COVID-19 treatments, saying they should not be used in the U.S. because of their ineffectiveness against the virus’ now-dominant Omicron variant.
